CD274 and melanoma: Recently, lipid calcium phosphate nanoparticles (LCPs) were used in the development of a vaccine against melanoma to deliver two essential components, including siRNA directed against the immunological checkpoint PD-L1 and mRNA encoding the tumor antigen TRP-2.